Navigation Links
Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks
Date:7/24/2014

Toronto, Canada (PRWEB) July 24, 2014

The first part of the session on “Best Practices for Optimizing Dose Escalation in First in Human Studies” will cover comprehensive clinical support in early phase studies to make better go/no-go decisions.

With increasing R&D costs and declining industry success in getting products to market, pharmaceutical companies need to maximize the knowledge collected in early Phase I/IIa study data to make better go/no-go decisions and improve success in late stage development.

Next, the presenters will examine steps to improve your dose selection and ultimately the value of your early clinical data. Using illustrative scenarios, they will explore key protocol design considerations along with essential pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation techniques.

Identifying the best dose escalation scheme in FIH studies is a critical and often underestimated step in early development decision-making. Likewise, setting up ideal study collection procedures is key to getting the most out of the subject data to efficiently produce an accurate understanding of your compound’s strengths and susceptibilities.

John the presenters, Dr. Seth Berry, Director, Clinical PK/PD Modeling & Simulation, & Center for Statistics in Drug Development at Quintiles, and Professor Tim Mant, Vice President, Medical Research and Principal Investigator at Quintiles, as they examine ways to:

  •     Optimize FIH study design from sampling plans to adjusting dose escalation based on tolerability and PK-PD during the course of the study for the most efficient and effective strategy
  •     Use PK-PD modeling and simulation to guide dosing for each cohort

Viewers will gain an understanding of ways to make the most of your early clinical development -- from efficiently conducting studies to providing dependable model predictions to optimize the overall process. These key factors in early drug development significantly improve the knowledge of the molecule at Proof of Concept, overall success or failure of compounds, and ultimately your return on investment.

For more information or to register for this webinar, visit: Best Practices for Optimizing Dose Escalation in First in Human Studies.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx.

Contact:
Michelle Tran
Tel: +1 (416) 977-6555 ext 352
Email: mtran(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2014/07/prweb12042363.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. All eligible Texas Childrens Pediatrics practices receive highest Patient Centered Medical Home Recognition from the National Committee for Quality Assurance
2. Certified Scrum Product Owner Training by Lonnie Weaver-Johnson in Richmond by Conscires Agile Practices
3. Best Practices in Patient Recruitment and Retention for Diabetes Trials, New Life Science Webinar Hosted by Xtalks
4. Key Findings from Social Media and Email Best Practices Guide for Marketing to Life Scientists
5. BioInformatics, LLC New Market Research Report – Social Media and Email Best Practices Guide for Marketing to Life Scientists
6. SCAI Paper Highlights Best Practices For Diagnosing And Treating Blocked Arteries Via The Wrist
7. Agile and Scrum Workshop – Values, Foundations, and Practices in San Diego, CA by Conscires Agile Practices
8. “Agile and Scrum – Values, Foundations, and Practices” in Philadelphia, PA- 8 PDUs
9. Affordable Pay It Forward Agile & Scrum Training Richmond, VA in by Conscires Agile Practices on Sept. 20
10. Affordable Scrum Training in London, UK on October 7th 2013 by Conscires Agile Practices
11. Announcing a Certified ScrumMaster Training on September 19-20, 2013 – 14 PDUs in Denver, CO by Conscires Agile Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
Breaking Biology News(10 mins):